Results 81 to 90 of about 23,835 (226)
Herpes zoster vaccine in Korea
Clinical and Experimental Vaccine Research, 2013 Herpes zoster and post-herpetic neuralgia deteriorate the quality of life because of severe pain and complications, and cause considerable social and economic burden of disease. In 2012, herpes zoster vaccine was released in Korea. The efficacy of herpes zoster vaccine is known to be 51.3-66.5% among the aged over 60 and 69.8-72.4% among adults between
openaire +2 more sources
Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome
Pediatric Dermatology, EarlyView.ABSTRACT Chediak–Higashi syndrome (CHS) is a rare autosomal recessive primary immunodeficiency characterized by partial oculocutaneous albinism, neurologic involvement, and a predisposition to severe infections. Patients are particularly susceptible to developing hemophagocytic lymphohistiocytosis (HLH), which significantly worsens prognosis. We report
Albane Badet +4 more
wiley +1 more source
The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014. [PDF]
, 2018 In Hong Kong, universal varicella vaccination started in July 2014. Before this, children could receive varicella vaccine via the private market. We analysed the epidemiology of varicella and zoster before universal vaccination.
Chan, DYW +7 more
core +1 more source
Vox Sanguinis, EarlyView.Abstract Background and Objectives Understanding differences in blood donor vaccine uptake is essential for accurately interpreting serosurveillance of vaccine‐preventable diseases and other research using donor samples and/or data. We aimed to assess vaccination uptake in donors and non‐donors.
Surendra Karki +5 more
wiley +1 more source
Vaccines for preventing herpes zoster in older adults
São Paulo Medical JournalBACKGROUND:Herpes zoster or, as it is commonly called, 'shingles' is a neurocutaneous disease characterised by the reactivation of varicella zoster virus (VZV), the virus that causes chickenpox, which is latent in the dorsal spinal ganglia when immunity ...
Ana M. Z. Gagliardi +3 more
doaj +1 more source
Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine
American Journal of Ophthalmology Case Reports, 2020 Purpose: Previously, secondary prevention of herpes zoster required live-attenuated vaccination, which is contraindicated in immunocompromised populations.
Rebecca I. Chen +3 more
doaj +1 more source
Protocol to Increase Administration of Herpes Zoster Vaccine in a Long-Term Care Facility [PDF]
, 2016 Although the herpes zoster (HZ) vaccine to decrease the incidence of Shingles was licensed for use in 2008, little coverage for HZ vaccination has occurred and stands nationally at 16%.
Mbola, Stephen, DNP, RN, ANP-BC
core
Dendritic cells as Achilles’ heel and Trojan horse during varicella zoster virus infection [PDF]
, 2015 Varicella zoster virus (VZV), a human alphaherpesvirus, causes varicella and subsequently establishes latency within sensory nerve ganglia. Later in life VZV can reactivate to cause herpes zoster.
Raftery, Martin J., Schönrich, Günther
core +2 more sources
ACR Open Rheumatology, Volume 8, Issue 3, March 2026.Objective Adults with rheumatic diseases are at increased risk for herpes zoster (HZ). Recommendations for the recombinant zoster vaccine (RZV) were expanded in 2021 to include those aged ≥19 years at increased risk for HZ due to immunodeficiency or immunosuppression because of disease or therapy, but the impact of these expanded recommendations is ...
Justin Carrico +7 more
wiley +1 more source
Herpes zoster: Epidemiological Features of the Incidence in 2019
Эпидемиология и вакцинопрофилактика, 2020 The urgency of the problem of herpes zoster (shingles) consists in its wide distribution in the world, high incidence rates in a significant part of the subjects of the Russian Federation, as well as the severity of complications caused by this infection.
A. N. Kaira, V. F. Lavrov
doaj +1 more source